Picoxystrobin belongs to FRAC Group 11 and disrupts normal energy metabolism by inhibiting the Qo site in the mitochondrial respiratory chain of the pathogen.
Cyproconazole belongs to FRAC Group 3 and disrupts the formation and function of the pathogen’s cell membrane by inhibiting sterol biosynthesis.
As the two active ingredients have different modes of action, they can be used to develop a combined fungicide targeting certain foliar fungal diseases.
Relevant applications may include wheat and other locally registered crops; however, the specific target diseases, application timing and efficacy must be determined based on the complete formulation dossier.
Importers should also pay attention to the registration status of cyproconazole in the target market, as well as the resistance management requirements for FRAC Group 11 active ingredients.
For SC formulations, particular attention should be paid to the suspension rate, particle size distribution and storage stability.
Supply Information
MaFa Agro provides supply enquiries regarding Picoxystrobin 200 g/L + Cyproconazole 80 g/L SC.
We can coordinate formulation specifications, packaging volumes, brand labelling and product quality documentation in accordance with customer requirements.